Westlake Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw $2.7B in sales and $235M EBITDA, with strong improvement from cost actions and global supply disruptions. PEM benefited from higher prices and volumes, while HIP rebounded after weather impacts. Full-year EBITDA uplift of $600M is targeted, with cautious guidance for HIP due to housing market uncertainty.
Fiscal Year 2025
-
Fourth quarter and full year 2025 results reflect significant restructuring, with $511 million in charges and $170 million in cost reductions. 2026 guidance anticipates $600 million in earnings improvement, driven by footprint optimization, cost savings, and plant reliability, with cautious optimism for both HIP and PEM segments.
-
Significant plant closures targeting high-cost, export-focused assets are set to deliver $175 million in free cash flow savings and $100 million in annual EBITDA improvement from 2026. Total profitability plan benefits are projected at $600 million, with all actions realized in 2026.
-
Q3 2025 saw lower sales and EBITDA due to weak PVC and HIP volumes, with a $727M impairment in chlorovinyls. Cost reduction and asset optimization are underway, with HIP showing resilience and PEM focused on restoring profitability. Guidance for 2025 is at the lower end of prior ranges.
-
Q2 2025 saw sequential improvement in HIP segment margins and sales, while PEM faced ongoing margin pressure from outages and global oversupply. Pernis epoxy site closure and expanded cost reduction targets aim to restore profitability, with HIP margins guided at 20–22% for 2025.
-
Q1 2025 saw a net loss of $40 million on $2.8 billion sales, with HIP margins resilient at 20% despite headwinds, while PEM margins compressed due to higher costs and outages. 2025 guidance was lowered for HIP, and cost reduction targets were raised as the company navigates macro and trade uncertainties.
-
HIP segment nearly doubled margins in six years, driven by organic growth, acquisitions, and vertical integration. Strong balance sheet supports further growth, with long-term tailwinds in housing and infrastructure. PEM faced Q4 headwinds, but innovation and capital discipline remain priorities.
Fiscal Year 2024
-
Q4 2024 saw year-over-year sales volume and EBITDA growth in both segments, with HIP achieving record results and PEM showing improved volumes despite price pressures. 2025 guidance anticipates stable HIP revenue and margins, continued cost reductions, and strong free cash flow, supported by a robust balance sheet.
-
Q3 2024 results were impacted by $120 million in unplanned maintenance outages and a $75 million mothball expense, leading to lower net income and EBITDA margins despite stable sales. HIP and PEM segments faced weather and market headwinds, but cost savings and a strong balance sheet support a positive outlook for 2025.
-
Record HIP segment results and strong cost savings drove year-over-year earnings growth, with robust volume and margin recovery in both HIP and PEM segments. Cautious optimism remains for the rest of 2024 amid macroeconomic and weather-related risks.
-
Revenue and EBITDA margin guidance for 2024 have been raised due to strong demand, backlog, and operational efficiencies. Growth is broad-based across all HIP business units, with margin expansion expected to continue through innovation and automation.